Order Article Reprints

Cheng M, Gao X, Wang Y, Chen H, He B, Xu H, Li Y, Han J, Zhang Z. Synthesis of Glycyrrhetinic Acid-Modified Chitosan 5-Fluorouracil Nanoparticles and Its Inhibition of Liver Cancer Characteristics in Vitro and in Vivo. Marine Drugs. 2013; 11(9):3517-3536. https://doi.org/10.3390/md11093517

Cheng, Mingrong, Xiaoyan Gao, Yong Wang, Houxiang Chen, Bing He, Hongzhi Xu, Yingchun Li, Jiang Han, and Zhiping Zhang. 2013. "Synthesis of Glycyrrhetinic Acid-Modified Chitosan 5-Fluorouracil Nanoparticles and Its Inhibition of Liver Cancer Characteristics in Vitro and in Vivo" Marine Drugs 11, no. 9: 3517-3536. https://doi.org/10.3390/md11093517

Cheng, M., Gao, X., Wang, Y., Chen, H., He, B., Xu, H., Li, Y., Han, J., & Zhang, Z. (2013). Synthesis of Glycyrrhetinic Acid-Modified Chitosan 5-Fluorouracil Nanoparticles and Its Inhibition of Liver Cancer Characteristics in Vitro and in Vivo. Marine Drugs, 11(9), 3517-3536. https://doi.org/10.3390/md11093517